Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Non-steroidal Anti-inflammatory Drugs (NSAID) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Non-steroidal Anti-inflammatory Drugs (NSAID) by Country/Region, 2017, 2022 & 2028

2.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type

2.2.1 Salicylates

2.2.2 Propionic acid derivatives

2.2.3 Acetic acid derivatives

2.2.4 Enolic acid (Oxicam) derivatives

2.2.5 Anthranilic acid derivatives (Fenamates)

2.2.6 Selective COX-2 inhibitors (Coxibs)

2.2.7 Sulfonanilides

2.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type

2.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2022)

2.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sale Price by Type (2017-2022)

2.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application

2.4.1 Human

2.4.2 Animals

2.4.3 Others

2.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application

2.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sale Market Share by Application (2017-2022)

2.5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sale Price by Application (2017-2022)

3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) by Company

3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Breakdown Data by Company

3.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Annual Sales by Company (2020-2022)

3.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Company (2020-2022)

3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Annual Revenue by Company (2020-2022)

3.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2020-2022)

3.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2020-2022)

3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sale Price by Company

3.4 Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Location Distribution

3.4.2 Players Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Non-steroidal Anti-inflammatory Drugs (NSAID) by Geographic Region

4.1 World Historic Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Geographic Region (2017-2022)

4.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Annual Revenue by Geographic Region

4.2 World Historic Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country/Region (2017-2022)

4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Annual Revenue by Country/Region

4.3 Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth

4.4 APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth

4.5 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth

4.6 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth

5 Americas

5.1 Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country

5.1.1 Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022)

5.1.2 Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022)

5.2 Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type

5.3 Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region

6.1.1 APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022)

6.1.2 APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022)

6.2 APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type

6.3 APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) by Country

7.1.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022)

7.1.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022)

7.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type

7.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) by Country

8.1.1 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022)

8.2 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type

8.3 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)

10.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)

10.4 Industry Chain Structure of Non-steroidal Anti-inflammatory Drugs (NSAID)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors

11.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Customer

12 World Forecast Review for Non-steroidal Anti-inflammatory Drugs (NSAID) by Geographic Region

12.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast by Region

12.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecast by Region (2023-2028)

12.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecast by Type

12.7 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecast by Application

13 Key Players Analysis

13.1 Bayer

13.1.1 Bayer Company Information

13.1.2 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

13.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer Main Business Overview

13.1.5 Bayer Latest Developments

13.2 Ecotrin

13.2.1 Ecotrin Company Information

13.2.2 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

13.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Ecotrin Main Business Overview

13.2.5 Ecotrin Latest Developments

13.3 Generic

13.3.1 Generic Company Information

13.3.2 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

13.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Generic Main Business Overview

13.3.5 Generic Latest Developments

13.4 St. Joseph

13.4.1 St. Joseph Company Information

13.4.2 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

13.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 St. Joseph Main Business Overview

13.4.5 St. Joseph Latest Developments

13.5 Elanco

13.5.1 Elanco Company Information

13.5.2 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

13.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Elanco Main Business Overview

13.5.5 Elanco Latest Developments

13.6 Zoetis

13.6.1 Zoetis Company Information

13.6.2 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

13.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Zoetis Main Business Overview

13.6.5 Zoetis Latest Developments

13.7 Boehringer Ingelheim

13.7.1 Boehringer Ingelheim Company Information

13.7.2 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

13.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Boehringer Ingelheim Main Business Overview

13.7.5 Boehringer Ingelheim Latest Developments

13.8 Merial

13.8.1 Merial Company Information

13.8.2 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

13.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Merial Main Business Overview

13.8.5 Merial Latest Developments

13.9 Merck Animal Health

13.9.1 Merck Animal Health Company Information

13.9.2 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

13.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Merck Animal Health Main Business Overview

13.9.5 Merck Animal Health Latest Developments

14 Research Findings and Conclusion

Table 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Non-steroidal Anti-inflammatory Drugs (NSAID) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Salicylates

Table 4. Major Players of Propionic acid derivatives

Table 5. Major Players of Acetic acid derivatives

Table 6. Major Players of Enolic acid (Oxicam) derivatives

Table 7. Major Players of Anthranilic acid derivatives (Fenamates)

Table 8. Major Players of Selective COX-2 inhibitors (Coxibs)

Table 9. Major Players of Sulfonanilides

Table 10. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)

Table 11. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2022)

Table 12. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & ($ million)

Table 13. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2022)

Table 14. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sale Price by Type (2017-2022) & (USD/Unit)

Table 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)

Table 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2022)

Table 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022)

Table 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2022)

Table 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sale Price by Application (2017-2022) & (USD/Unit)

Table 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company (2020-2022) & (K Units)

Table 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Company (2020-2022)

Table 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2020-2022) ($ Millions)

Table 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2020-2022)

Table 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sale Price by Company (2020-2022) & (USD/Unit)

Table 25. Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Producing Area Distribution and Sales Area

Table 26. Players Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered

Table 27. Non-steroidal Anti-inflammatory Drugs (NSAID) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 28. New Products and Potential Entrants

Table 29. Mergers & Acquisitions, Expansion

Table 30. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Geographic Region (2017-2022) & (K Units)

Table 31. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share Geographic Region (2017-2022)

Table 32. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 33. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Geographic Region (2017-2022)

Table 34. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country/Region (2017-2022) & (K Units)

Table 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country/Region (2017-2022)

Table 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country/Region (2017-2022) & ($ millions)

Table 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country/Region (2017-2022)

Table 38. Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)

Table 39. Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2017-2022)

Table 40. Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & ($ Millions)

Table 41. Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2017-2022)

Table 42. Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)

Table 43. Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2022)

Table 44. Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)

Table 45. Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2022)

Table 46. APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022) & (K Units)

Table 47. APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2022)

Table 48. APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022) & ($ Millions)

Table 49. APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2017-2022)

Table 50. APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)

Table 51. APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2022)

Table 52. APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)

Table 53. APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2022)

Table 54. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)

Table 55. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2017-2022)

Table 56. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & ($ Millions)

Table 57. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2017-2022)

Table 58. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)

Table 59. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2022)

Table 60. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)

Table 61. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2022)

Table 62. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)

Table 63. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2017-2022)

Table 64. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & ($ Millions)

Table 65. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2017-2022)

Table 66. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)

Table 67. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2022)

Table 68. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)

Table 69. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2022)

Table 70. Key Market Drivers & Growth Opportunities of Non-steroidal Anti-inflammatory Drugs (NSAID)

Table 71. Key Market Challenges & Risks of Non-steroidal Anti-inflammatory Drugs (NSAID)

Table 72. Key Industry Trends of Non-steroidal Anti-inflammatory Drugs (NSAID)

Table 73. Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Material

Table 74. Key Suppliers of Raw Materials

Table 75. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List

Table 76. Non-steroidal Anti-inflammatory Drugs (NSAID) Customer List

Table 77. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Region (2023-2028) & (K Units)

Table 78. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Forecast by Region

Table 79. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share Forecast by Region (2023-2028)

Table 81. Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Region (2023-2028) & (K Units)

Table 84. APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 85. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Country (2023-2028) & (K Units)

Table 88. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Type (2023-2028) & (K Units)

Table 90. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share Forecast by Type (2023-2028)

Table 91. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 92. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share Forecast by Type (2023-2028)

Table 93. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Application (2023-2028) & (K Units)

Table 94. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share Forecast by Application (2023-2028)

Table 95. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 96. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share Forecast by Application (2023-2028)

Table 97. Bayer Basic Information, Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base, Sales Area and Its Competitors

Table 98. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

Table 99. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Bayer Main Business

Table 101. Bayer Latest Developments

Table 102. Ecotrin Basic Information, Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base, Sales Area and Its Competitors

Table 103. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

Table 104. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Ecotrin Main Business

Table 106. Ecotrin Latest Developments

Table 107. Generic Basic Information, Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base, Sales Area and Its Competitors

Table 108. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

Table 109. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Generic Main Business

Table 111. Generic Latest Developments

Table 112. St. Joseph Basic Information, Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base, Sales Area and Its Competitors

Table 113. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

Table 114. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. St. Joseph Main Business

Table 116. St. Joseph Latest Developments

Table 117. Elanco Basic Information, Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base, Sales Area and Its Competitors

Table 118. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

Table 119. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Elanco Main Business

Table 121. Elanco Latest Developments

Table 122. Zoetis Basic Information, Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base, Sales Area and Its Competitors

Table 123. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

Table 124. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Zoetis Main Business

Table 126. Zoetis Latest Developments

Table 127. Boehringer Ingelheim Basic Information, Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base, Sales Area and Its Competitors

Table 128. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

Table 129. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Boehringer Ingelheim Main Business

Table 131. Boehringer Ingelheim Latest Developments

Table 132. Merial Basic Information, Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base, Sales Area and Its Competitors

Table 133. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

Table 134. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Merial Main Business

Table 136. Merial Latest Developments

Table 137. Merck Animal Health Basic Information, Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base, Sales Area and Its Competitors

Table 138. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered

Table 139. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Merck Animal Health Main Business

Table 141. Merck Animal Health Latest Developments

List of Figures

Figure 1. Picture of Non-steroidal Anti-inflammatory Drugs (NSAID)

Figure 2. Non-steroidal Anti-inflammatory Drugs (NSAID) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Salicylates

Figure 10. Product Picture of Propionic acid derivatives

Figure 11. Product Picture of Acetic acid derivatives

Figure 12. Product Picture of Enolic acid (Oxicam) derivatives

Figure 13. Product Picture of Anthranilic acid derivatives (Fenamates)

Figure 14. Product Picture of Selective COX-2 inhibitors (Coxibs)

Figure 15. Product Picture of Sulfonanilides

Figure 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type in 2021

Figure 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2022)

Figure 18. Non-steroidal Anti-inflammatory Drugs (NSAID) Consumed in Human

Figure 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market: Human (2017-2022) & (K Units)

Figure 20. Non-steroidal Anti-inflammatory Drugs (NSAID) Consumed in Animals

Figure 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market: Animals (2017-2022) & (K Units)

Figure 22. Non-steroidal Anti-inflammatory Drugs (NSAID) Consumed in Others

Figure 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market: Others (2017-2022) & (K Units)

Figure 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2022)

Figure 25. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application in 2021

Figure 26. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company in 2021

Figure 28. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Geographic Region in 2021

Figure 30. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2022)

Figure 31. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country/Region in 2021

Figure 32. Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Sales 2017-2022 (K Units)

Figure 33. Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue 2017-2022 ($ Millions)

Figure 34. APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales 2017-2022 (K Units)

Figure 35. APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue 2017-2022 ($ Millions)

Figure 36. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales 2017-2022 (K Units)

Figure 37. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales 2017-2022 (K Units)

Figure 39. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue 2017-2022 ($ Millions)

Figure 40. Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country in 2021

Figure 41. Americas Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country in 2021

Figure 42. United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region in 2021

Figure 47. APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Regions in 2021

Figure 48. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country in 2021

Figure 55. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country in 2021

Figure 56. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country in 2021

Figure 63. Egypt Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) in 2021

Figure 69. Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)

Figure 70. Industry Chain Structure of Non-steroidal Anti-inflammatory Drugs (NSAID)

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles